Thoracoscopic lobectomy: a safe and effective strategy for patients with stage i lung cancer

摘要: Abstract Background . Thoracoscopic lobectomy is emerging as a potential alternative to thoracotomy for early stage lung cancer. The issues of safety and oncologic efficacy should be analyzed before recommending this procedure widespread use. Methods was attempted in 110 consecutive patients (age, 35 81years) with tumors that were judged amenable over 26-month period. Exclusion criteria included greater than 5 cm diameter, T3 tumors, endobronchial visible at bronchoscopy, the use induction therapy, extensive N1 disease on computed tomographic scan, N2 mediastinoscopy. procedures performed without rib spreading using two ports anatomic hilar dissection individual vessel stapling. Results mediastinal lymph successfully 108 (98.2%); 2 required conversion control bleeding setting dense adenopathy. There no intraoperative deaths 4 perioperative (3.6%) caused by pneumonia associated adult respiratory distress syndrome (3 patients) stroke (1 patient). Major complications (5 patients), patient), return operating room revise bronchial closure Minor prolonged air leak (6 atrial fibrillation (4 blood transfusion (2 ileus Median time chest tube removal 3 days, median length stay days. Conclusions safe effective strategy Long-term follow-up determine if recurrence rate 5-year survival are comparable lobectomy.